FundedIQ
Biotechnology

SCG Cell Therapy: Funding, Investors & Team (Sep 2026)

The objective of SCG Cell Therapy is to utilize the patient's immune system to combat infections and antigens that cause cancer, while also striving to create new immunotherapies for treating patients afflicted with cancer and pathogenic infections.

www.scgcell.com LinkedIn Singapore, Singapore 51-100 employees
Biotechnology Life Science B2B Cell therapy Bispecific antibody Immunotherapy Scientific research Therapeutic vaccine
Total raised
$8.1M
Rounds
1
Latest
Series C
Apr 2023

SCG Cell Therapy has raised $8.1M across 1 funding round on record, the most recent a Series C of $8.1M announced in Apr 2023.

That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

SCG Cell Therapy Company Profile and Key Stats

Total funding raised
$8.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series C
$8.1M in Apr 2023
Employees
51-100
reported band
Headquarters
Singapore, Singapore

Latest funding round on record: Apr 2023.

SCG Cell Therapy Funding Rounds

Date
Round
Amount
Series C
$8.1M

SCG Cell Therapy Founders and Leadership Team

Name
Role
Contact
Peter
Founder

No contact details are on record for this team yet.

SCG Cell Therapy Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,182
$8.0M
987
$5.0M
1,822
$58M

SCG Cell Therapy's latest round of $8.1M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like SCG Cell Therapy in Biotechnology and Singapore

Companies Similar to SCG Cell Therapy

YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…

Seed $2.6M

Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…

Undisclosed round $4.6M

ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…

Undisclosed round

Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…

Series B $45.0M

Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…

Undisclosed round

Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…

Undisclosed round $40.0M

BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…

Pre-Seed $100k

Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…

Seed $4.0M

ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…

Undisclosed round $5.0M

GDMC is a pharmaceutical organization that specializes in the production and development of genetic…

Series A $21.0M

Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…

Seed $3.8M

Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…

Undisclosed round $6.0M

SCG Cell Therapy Funding FAQs

What does SCG Cell Therapy do?

The objective of SCG Cell Therapy is to utilize the patient's immune system to combat infections and antigens that cause cancer, while also striving to create new immunotherapies for treating patients afflicted with cancer and pathogenic infections.

How much funding has SCG Cell Therapy raised?

SCG Cell Therapy has raised $8.1M across 1 round on record. The most recent is a Series C of $8.1M announced in Apr 2023.

When did SCG Cell Therapy last raise funding?

SCG Cell Therapy's most recent funding round on record is a Series C of $8.1M, announced in Apr 2023.

Who founded SCG Cell Therapy?

FundedIQ lists Peter (Founder) at SCG Cell Therapy.

Where is SCG Cell Therapy headquartered?

SCG Cell Therapy is based in Singapore, Central Region, Singapore.

How many employees does SCG Cell Therapy have?

SCG Cell Therapy is in the 51-100 employee band.

How does SCG Cell Therapy's funding compare to other Biotechnology startups?

SCG Cell Therapy's latest round of $8.1M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's SCG Cell Therapy Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SCG Cell Therapy is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.